Expand REGN Menu
REGN MENU

REGN Stock Posts


Unusual Option Volume

REGN Regeneron Pharmaceuticals748.83+46.96 (+6.7%)

Regeneron Pharmaceuticals trades 1,706 contracts. The company has the following event: 8th Annual Evercore Healthcare Conference on Dec 2, 2025. News: EYLEA HD (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications
View Details...
Unusual Option Volume

REGN Regeneron Pharmaceuticals704.45-20.89 (-2.9%)

Regeneron Pharmaceuticals trades 7,867 contracts. The company has the following event: 8th Annual Evercore Healthcare Conference on Dec 2, 2025. News: Libtayo (cemiplimab) Approved in the European Union as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with High Risk of Recurrence after Surgery and Radiation
View Details...
Unusual Option Volume

REGN Regeneron Pharmaceuticals631.39+46.08 (+7.9%)

Regeneron Pharmaceuticals trades 1,979 contracts. News: Regeneron Reports Third Quarter 2025 Financial and Operating Results
View Details...
$REGN Earnings October 28 BMO. Expected Move ±7.1% vs Prev. Move +2.5%
Unusual Option Volume

REGN Regeneron Pharmaceuticals549.82-14.81 (-2.6%)

Regeneron Pharmaceuticals trades 1,371 contracts. REGN will report earnings on Oct 28, 2025.
View Details...
Unusual Option Volume

REGN Regeneron Pharmaceuticals605.84+43.57 (+7.8%)

Regeneron Pharmaceuticals trades 2,020 contracts. REGN will report earnings on Oct 28, 2025. News: Regeneron to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on October 28, 2025
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes